The Association of Increasing Body Mass Index and Kidney Stone Disease
To access this article, please choose from the options below
Supported by The Hariri Family Foundation, and Mr. and Mrs. Chad and Nissa Richison.
Supported by Grant T32DK07552 from the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases. The contents are solely the responsibility of the author, and do not necessarily represent the official views of the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases.
The data set used in this study was originally created for a different research project on patterns of obesity care within selected BCBS plans. The previous research project (but not the current study) was funded by unrestricted research grants from Ethicon Endo-Surgery, Inc. (a Johnson & Johnson company); Pfizer, Inc and GlaxoSmithKline.
See Editorial on page 427.
For another article on a related topic see page 759.
PII: S0022-5347(09)02626-3
doi:10.1016/j.juro.2009.09.085
© 2010 American Urological Association. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Body Mass Index as a Predictor of Urological Disease and Outcomes—Overly Simplistic? , 14 December 2009
- Ethylene Glycol Induced Hyperoxaluria Increases Plasma and Renal Tissue Asymmetrical Dimethylarginine in Rats: A New Pathogenetic Link in Hyperoxaluria Induced Disorders , 17 December 2009